Skip to main content
TYK Medicines, Inc logo

TYK Medicines, Inc — Investor Relations & Filings

Ticker · 2410 ISIN · CNE100006L34 HKEX Manufacturing
Open in API
Filings indexed 870 across all filing types
Latest filing 2025-03-28 Annual Report
Country HK Hong Kong
Listing HKEX 2410

About TYK Medicines, Inc

https://www.tykmedicines.com

TYK Medicines, Inc. is a clinical-stage biopharmaceutical company specializing in the discovery, development, and commercialization of innovative small-molecule targeted therapies. The company leverages a proprietary small molecule drug design and screening platform, with a primary strategic focus on oncology, particularly treatments for lung cancer. The lead pipeline asset, TY-9591 (Edotamidine mesylate), an EGFR-targeted therapy, is currently in the Pre-NDA stage, having demonstrated promising clinical efficacy in treating lung cancer patients with brain metastasis. The pipeline also includes assets such as TY-302 and TY-2136, alongside multiple CDK inhibitors in clinical development, reflecting a commitment to addressing unmet medical needs in targeted cancer treatment.

Recent filings

Filing Released Lang Actions
2024 ANNUAL RESULTS ANNOUNCEMENT
Annual Report Classification · 95% confidence The document is titled '2024 Annual Results Announcement' and contains detailed consolidated financial statements including profit or loss, comprehensive income, and financial position for the year ended 31 December 2024. It includes extensive financial data, notes on basis of preparation, adoption of new accounting standards, segment information, and detailed revenue breakdowns. The length is about 15,000 characters, indicating a full report rather than a brief announcement. The content corresponds to a comprehensive annual financial report rather than a short earnings release or a simple announcement. Therefore, this document is best classified as an Annual Report (10-K equivalent). FY 2024
2025-03-28 English
2024 ANNUAL RESULTS ANNOUNCEMENT
Annual Report Classification · 95% confidence The document is titled '2024 Annual Results Announcement' and contains detailed consolidated financial statements including profit or loss, comprehensive income, and financial position for the year ended 31 December 2024. It includes extensive financial data, notes on basis of preparation, adoption of new accounting standards, segment information, and major customer revenue breakdown. The length is about 15,000 characters, indicating a full report rather than a brief announcement. The content corresponds to a comprehensive annual financial report covering the full fiscal year, which matches the definition of an Annual Report (10-K). There is no indication that this is merely an announcement of a report or a certification letter, so it is not RPA or RNS. Therefore, the document is classified as an Annual Report (10-K). FY 2024
2025-03-28 English
2024 ANNUAL RESULTS ANNOUNCEMENT
Earnings Release Classification · 90% confidence The document is the company’s 2024 Annual Results Announcement released on the Hong Kong stock exchange, containing highlighted financial results for the year ended 31 December 2024 along with consolidated financial statements and notes. It is the preliminary announcement of annual results (not the full statutory annual report), which corresponds to an initial earnings release for the year. Therefore, it should be classified as an Earnings Release. FY 2024
2025-03-28 English
TERMS OF REFERENCE OF THE NOMINATION COMMITTEE OF THE BOARD OF DIRECTORS
Governance Information Classification · 92% confidence The document is the “Terms of Reference of the Nomination Committee of the Board of Directors,” detailing the internal rules, composition, duties, authorities, and procedures of a board committee. This aligns with a governance information report outlining the company’s board structure and governance practices. It is not announcing a board change nor is it a financial or operational report, but a governance charter. Therefore, it fits the Governance Information category (CGR).
2025-03-27 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information Classification · 82% confidence The document provides an official listing of the company’s board of directors, categorizes them by executive/non-executive status, and details their committee memberships. It is not an annual report, earnings release, or other financial disclosure. Instead, it is a corporate announcement of the company’s board composition and management structure, fitting the Board/Management Information category.
2025-03-27 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2024&#x3b; RESIGNATION OF NON-EXECUTIVE DIRECTOR&#x3b; AND PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION
Annual Report Classification · 100% confidence The document is titled 'ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2024' and contains detailed audited consolidated financial statements including profit or loss, comprehensive income, financial position, notes to the consolidated financial statements, accounting policies, and segment information. It references the audit by Ernst & Young and includes extensive financial data for the full fiscal year ending December 31, 2024. The length of the document (15,000 characters) and the presence of full financial statements and notes indicate this is the full annual report rather than a brief announcement or summary. Therefore, this document fits the definition of an Annual Report (10-K). FY 2024
2025-03-27 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.